MEDI-517 (GSK 580299)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MEDI-517 (GSK 580299), covering 2016-09-16 to 2016-09-16. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females [Phase 2]